TickerFactsScreenerDevelopers

Larimar Therapeutics, Inc. (LRMR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$40.92M2012: -$54.73M2013: -$68.57M2014: $104.44M2015: $169.11M2016: $121.73M2017: $78.22M2018: $2.91M2019: -$694.0K2020: $89.69M2021: $64.41M2022: $110.90M2023: $81.72M2024: $171.81M2025: $78.08M$78.08M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$78.08M-54.6%
2024$171.81M+110.2%
2023$81.72M-26.3%
2022$110.90M+72.2%
2021$64.41M-28.2%
2020$89.69M+13023.9%
2019-$694.0K-123.8%
2018$2.91M-96.3%
2017$78.22M-35.7%
2016$121.73M-28.0%
2015$169.11M+61.9%
2014$104.44M+252.3%
2013-$68.57M-25.3%
2012-$54.73M-33.8%
2011-$40.92M—